1. 103655468 Fusion protein Exendin-4-HSA solution stabilizing preparation
CN
26.03.2014
A61K 9/08 Loading...
A61K 9/08
Loading...
201310630500.9
无锡和邦生物科技有限公司
杨建良
A61K 9/08
Loading...
The invention discloses a fusion protein Exendin-4-HSA solution stabilizing preparation, and belongs to the field of research on pharmaceutical preparations. The Exendin-4-HSA solution stabilizing preparation comprises effective components of Exendin-4-HAS fusion protein, a phosphate buffer system, a surfactant F68, an osmotic pressure maintaining agent mannitol, a preservative metacresol, sodium caprylate and EDTA. The fusion protein Exendin-4-HSA solution stabilizing preparation can effectively improve the stability of the fusion protein Exendin-4-HSA and can prolong the shelf life and improve the applicability of the fusion protein Exendin-4-HSA so as to improve the therapeutic value of the fusion protein Exendin-4-HAS for treating type-2 diabetes and obesity.
2. 203107876 一次性防拆医用笔式注射器
CN
07.08.2013
A61M 5/24 Loading...
A61M 5/24
Loading...
201320074591.8
无锡和邦生物科技有限公司
杨建良
A61M 5/24
Loading...
一次性防拆医用笔式注射器，属医疗器械领域中的药物给药系统。本实用新型由笔套（1）、针头螺口（2）、储药瓶外套（3）、推杆（4）、防拆装置（5）、笔身螺纹（6）、释放按钮（7）、笔身（8）和剂量调节钮（9）组成；特点是使用卡式瓶作为储药瓶（笔芯），卡式瓶装入笔式注射器后不能再完整取出，待卡式瓶内注射液用完后此笔式注射器不能再重复使用，保证患者在达到规定的使用次数后不能再装药后重复使用，具有防伪作用：同时确保不会因长期使用而带来一系列问题，如计量不准、使用不规范带来的卫生安全问题等。另外此笔式注射器采用非连续计量读数调节钮设计，根据每次用药量设计多个档位读数，保证每次用药量的精确性，使用更加方便。
3. 103100130 一次性防拆医用笔式注射器
CN
15.05.2013
A61M 5/24 Loading...
A61M 5/24
Loading...
201310051866.0
无锡和邦生物科技有限公司
杨建良
A61M 5/24
Loading...
一次性防拆医用笔式注射器，属医疗器械领域中的药物给药系统。本发明公开一种具有防伪作用的、用于胰岛素注射或其他注射类药品的笔式注射器，特点是可以使用卡式瓶作为储药瓶（笔芯），卡式瓶装入笔式注射器后不能再完整取出，待卡式瓶内注射液用完后此笔式注射器即不能再重复使用，从而保证患者在使用此笔式注射器达到规定的使用次数后不能再装药后重复使用，具有防伪作用，同时确保此笔式注射器不会因长期使用而带来一系列问题，如计量不准、使用不规范带来的卫生安全问题等。另外此笔式注射器采用非连续计量（或称非累计式）读数调节钮设计，根据每次用药量设计多个档位读数，更能保证每次用药量的精确性，而且使用更加方便。
4. 202161638 一次性防拆笔式注射器
CN
14.03.2012
A61M 5/178 Loading...
A61M 5/178
Loading...
201120208862.5
无锡和邦生物科技有限公司
杨建良
A61M 5/178
Loading...
一次性防拆笔式注射器，属医疗器械领域中的药物给药系统。本实用新型公开一种具有防伪作用的一次性笔式注射器。特点是可以使用卡式瓶作为储药瓶（笔芯），卡式瓶装进笔式注射器后不能再完整取出，待卡式瓶内注射液用完后即不可再重复使用，从而可以保证患者在使用此注射器达到规定的使用次数后不再装药后重复使用，具有防伪作用，同时确保注射器不会因长期使用而带来一系列问题，如计量不准、使用不规范带来的卫生安全问题等。另外本实用新型采用非连续计量（或称非累计式）读数调节钮设计，并可根据用药量设计多个档位读数，这样的设计更能保证每次用药量的精确性，而且使用更加方便。
5. 102247636 Disposable tamper pen type injector
CN
23.11.2011
A61M 5/178 Loading...
A61M 5/178
Loading...
201110166244.3
Wuxi Hebang Biological Technology Co.,Ltd.
Yang Jianliang
A61M 5/178
Loading...
The invention relates to a disposable tamper pen type injector, belongs to a drug delivery system in the field of medical instruments, and discloses a disposable pen type injector with an anti-counterfeit effect. The injector is characterized in that: a clamp type bottle can be used as a drug storage bottle (a pen core) and cannot be completely taken out after being assembled into the pen type injector; after injection in the clamp type bottle is consumed, the injector cannot be reused, so that the injector is not filled again for reuse after being used for a specified number of times by a patient, the anti-counterfeit effect is achieved, and a series of problems, such as health and safety problems caused by inaccurate metering and nonstandard use and the like, brought by long-term use of the injector are avoided. In addition, a non-continuous metering (or non-cumulative) reading adjusting button is designed, and a plurality of gear readings can be designed according to dosage, so that the accuracy of the dosage each time can be guaranteed, and the injector is more convenient to use.
6. 101875700 Method for improving bioactivity of exendin fusion protein
CN
03.11.2010
C07K 19/00 Loading...
C07K 19/00
Loading...
201010142436.6
Jiangsu Institute of Parasitic Diseases
Yang Jianliang
C07K 19/00
Loading...
The invention discloses a method for improving the bioactivity of an exendin fusion protein, which belongs to the technical field of biopharmaceuticals. In the method, an Exendin-4 and GLP-1 are connected in series first and then are connected with human serum albumin HSA or human immunoglobulin Fc to form the fusion protein, so as to increase the bioactivity of the exendin fusion protein. The fusion protein is expressed as: (Exendin-4-GLP-1)n-HSA, (GLP-1-Exendin-4)n-HSA, (Exendin-4-GLP-1)n-Fc or (GLP-1-Exendin-1)n-Fc, wherein the value of n ranges from 1 to 5. The fusion protein prepared by the method has higher bioactivity than a fusion protein Exendin-4-HSA or a GLP-1-HSA protein. The fusion protein of the invention can be used for preparing medicaments for treating non-insulin-dependent diabetes, various symptoms of the non-insulin-dependent diabetes and obesity.
7. 101240033 Fusion protein of insulin secretion accelerating peptide and human serum albumin, and preparation method thereof
CN
13.08.2008
C07K 19/00 Loading...
C07K 19/00
Loading...
200810018639.7
Wuxi Hebang Biological Technology Co., Ltd.
Yang Jianliang
C07K 19/00
Loading...
A fusion protein for insulinotropic hormone secretion peptide and human blood serum albumin, and preparation thereof, which pertains to long-acting recombinant fusion protein technical field. The invention relates to fusion protein for insulinotropic hormone secretion peptide (Exendin-4) and human blood serum albumin (HSA), which contains two polypeptide area, wherein the first area comprises a plurality of insulinotropic hormone secretion peptide Exendin-4 repeats, the second area comprises human blood serum albumin HSA. The first area is directly connected to N-terminal of the second area through C-terminal thereof, without any connecting peptide therebetween. The formula is: (Exendin-4)n-HSA, wherein n is repeat times of Exendin-4 repeats, which is 2-8. Application of the (Exendin-4)n-HSA fusion protein can stabilize blood glucose level of mammals, so that it can be used in preparation of remedies for non-insulin-dependent diabetes mellitus and obesity, which has higher stability and longer half-life compared to Exendin-4 compound.

